Mathieu, Chantal, Wych, Julie, Hendriks, A. Emile J., Van Ryckeghem, Lisa, Tree, Timothy, Chmura, Piotr, Möller, Christopher, Casteels, Kristina, Danne, Thomas, Reschke, Felix, Šmigoc Schweiger, Darja, Battelino, Tadej, Johannesen, Jesper, Rami-Merhar, Birgit, Pieber, Thomas, De Block, Christophe, Evans, Mark, Hilbrands, Robert, Bosi, Emanuele, Willemsen, Ruben H., Basu, Supriyo, Pulkkinen, Mari-Anne, Knip, Mikael, Cnop, Miriam, Nitsche, Almut, Schulte, Anke M., Niemöller, Elisabeth, Peakman, Mark, Wilhelm-Benartzi, Charlotte  ORCID: https://orcid.org/0000-0003-4927-6158, Gillespie, David  ORCID: https://orcid.org/0000-0002-6934-2928, Overbergh, Lut, Mander, Adrian  ORCID: https://orcid.org/0000-0002-0742-9040, Marcovecchio, M. Loredana, Mathieu, Chantal, Overbergh, Lutgart, Evans, Mark, Hendriks, A. Emile J., Marcovecchio, M. Loredana, Peakman, Mark, Tree, Timothy, Morgan, Noel G., Todd, John A., Wicker, Linda, Mander, Adrian P., Dayan, Colin M, Wych, Julie, Gillespie, David, Pieber, Thomas, Eizirik, Decio L., Cnop, Miriam, Brunak, Søren, Pociot, Flemming, Johannesen, Jesper, Mallone, Roberto, Knip, Mikael, Otonkoski, Timo, Veijola, Riitta, Lahesmaa, Riitta, Ziegler, Anette G., Solimena, Michele, Bonifacio, Ezio, Holl, Reinhard, Dotta, Francesco, Chiarelli, Francesco, Marchetti, Piero, Bosi, Emanuele, Cianfarani, Stefano, de Beaufort, Carine, Dahl-Jørgensen, Knut, Jarosz-Chobot, Przemyslawa, Battelino, Tadej, Gotthardt, Martin, Roep, Bart O., Lundgren, Markus, Costecalde, Guillaume, von Herrath, Matthias, Napolitano-Rosen, Antonella, Niemöller, Elisabeth, Keil, Stefanie, Dutta, Sanjoy, Latres, Esther, Agiostratidou, Gina and Koralova, Anne
      2025.
      
      Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial.
      The Lancet
      406
      
        (10510)
      
      , pp. 1375-1388.
      
      10.1016/s0140-6736(25)01674-5
    
  
  
      Item availability restricted.  | 
    
| 
        
  
  
       | 
    
        
  
  
      Wych, Julie, Brunner, Martina, Stenson, Rachel, Chumura, Piotr Jaroslaw, Danne, Thomas, Mander, Adrian Paul  ORCID: https://orcid.org/0000-0002-0742-9040, Mathieu, Chantal, Dayan, Colin  ORCID: https://orcid.org/0000-0002-6557-3462 and Pieber, Thomas R.
      2024.
      
      Investigating the effect of verapamil on preservation of beta-cell function in adults with newly diagnosed type 1 diabetes mellitus (Ver-A-T1D): protocol for a randomised, double-blind, placebo-controlled, parallel-group, multicentre trial.
      BMJ Open
      14
      
        (11)
      
      
      , e091597.
      10.1136/bmjopen-2024-091597
    
  
    
    
       
    
  
  
       | 
    
| 
        
  
  
       | 
    
        
  
  
      Othman, Jad, Wilhelm-Benartzi, Charlotte S.  ORCID: https://orcid.org/0000-0003-4927-6158, Dillon, Richard, Knapper, Steven  ORCID: https://orcid.org/0000-0002-6405-4441, Freeman, Sylvie D., Batten, Leona M., Canham, Joanna  ORCID: https://orcid.org/0000-0003-3482-0990, Hinson, Emily L., Wych, Julie, Betteridge, Sophie, Villiers, William, Kleeman, Michelle, Gilkes, Amanda Frances, Potter, Nicola, Overgaard, Ulrik, Mehta, Priyanka, Kottaridis, Panagiotis, Cavenagh, Jamie, Hemmaway, Claire Jane, Arnold, Claire, Dennis, Mike and Russell, Nigel H.
      2023.
      
      A randomised comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial.
      Blood Advances
      7
      
        (16)
      
      , pp. 4539-4549.
      
      10.1182/bloodadvances.2023010276
    
  
    
    
       
    
  
  
       | 
    
| 
        
  
  
       | 
    
        
  
  
      Jayson, G., Carucci, Margherita, Hurt, Christopher  ORCID: https://orcid.org/0000-0003-1206-8355, Zhou, Cong, Monaghan, Phillip, Wych, Julie, Irving, Alys, Narasimham, Monica, Morrison, Hilary, Campbell, Sue, Glasspool, Rosalind, Longo, Mirella  ORCID: https://orcid.org/0000-0002-9867-3806, Nelson, Annmarie  ORCID: https://orcid.org/0000-0002-6075-8425, Dive, Caroline, Adams, Richard  ORCID: https://orcid.org/0000-0003-3915-7243 and Clamp, Andrew
      2021.
      
      VALTIVE1: Validation of Tie2 as a response biomarker for VEGF inhibitors In Ovarian Cancer.
      Presented at: NCRI Cancer Conference,
      
      2021.
      
      
      
      
      
       
      
      
      
      
      
    
  
  
       
       
     
       | 
    
        
  
  
       
    
       | 
    
        
  
  
      Wych, Julie, Grayling, Michael J. and Mander, Adrian P.  ORCID: https://orcid.org/0000-0002-0742-9040
      2019.
      
      Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study.
      Trials
      20
      
        (1)
      
      
      , 665.
      10.1186/s13063-019-3724-6
    
  
    
    
       
    
  
  
       | 
    
| 
        
  
  
       | 
    
        
  
  
      Stather, Philip W., Wych, Julie and Boyle, Jonathan R.
      2019.
      
      A systematic review and meta-analysis of remote ischemic preconditioning for vascular surgery.
      Journal of Vascular Surgery
      70
      
        (4)
      
      , pp. 1353-1363.
      
      10.1016/j.jvs.2019.03.025
    
  
    
    
       
    
  
  
       | 
    
| 
        
  
  
       | 
    
        
  
  
      Mukhtar, Omar, Cheriyan, Joseph, Cockcroft, John R., Collier, David, Coulson, James M., Dasgupta, Indranil, Faconti, Luca, Glover, Mark, Heagerty, Anthony M., Khong, Teck K., Lip, Gregory Y.H., Mander, Adrian P., Marchong, Mellone N., Martin, Una, McDonnell, Barry J., McEniery, Carmel M., Padmanabhan, Sandosh, Saxena, Manish, Sever, Peter J., Shiel, Julian I., Wych, Julie, Chowienczyk, Phil J. and Wilkinson, Ian B.
      2018.
      
      A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program—AIM-HY INFORM trial.
      American Heart Journal
      204
      
      , pp. 102-108.
      
      10.1016/j.ahj.2018.05.006
    
  
    
    
       
    
  
  
       | 
    
| 
        
  
  
       | 
    

							

 Up a level